BioMed Research International / 2010 / Article / Fig 8

Research Article

Construction and Characterization of a Novel Fusion Protein MG7-scFv/SEB against Gastric Cancer

Figure 8

Ten gastric-cancer-bearing rats in each group were observed for their survival time after being administrated with MG7-scFv/SEB, SEB, or NS. The survival times of the rats in MG7-scFv/SEB and SEB group were longer than that of NS group within 60-day observation ( 𝑃 < . 0 5 ). There were statistic differences among the three groups ( 𝑃 < . 0 5 ).